Skip to main content
Clinical Trials/NCT05277025
NCT05277025RecruitingNot Applicable

Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes

University of Florida2 sites in 1 country150 target enrollmentStarted: March 22, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
150
Locations
2
Primary Endpoint
Pressure Pain Thresholds

Study Overview

Brief Summary

Fibromyalgia (FM) is a chronic musculoskeletal pain disorder that afflicts up to 4% of the general population. The evaluation of pain mechanisms in FM has shown predominant central abnormalities and therefore has been designated as nociplastic pain syndrome. Rheumatoid arthritis (RA) is characterized by polyarthritis and pain from inflamed tissues, consistent with nociceptive pain. FM and RA patients may utilize overlapping pain mechanisms resulting in nociceptive and nociplastic pain.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Ages 18-70
  • Fulfills the 1990 and 2011 American College of Rheumatology Criteria for FM
  • Fulfills the 2010 ACR-EULAR classification criteria for RA
  • Healthy volunteers: No significant pain/fatigue/depression/anxiety.

Exclusion Criteria

  • Advanced liver, kidney or cardiovascular disease
  • Neuropathic pain

Arms & Interventions

Fibromyalgia

Participants who fulfill the 1990 and 2011 American College of Rheumatology Criteria for FM.

Rheumatoid Arthritis

Participants who fulfill the 2010 American College of Rheumatology (ACR)-European League against rheumatism (EULAR) classification criteria for RA.

Healthy Volunteers

Participants who do not have significant pain/fatigue/anxiety/depression.

Outcomes

Primary Outcomes

Pressure Pain Thresholds

Time Frame: One hour

Using an algometer pressure pain thresholds will be obtained several times at the upper and lower extremities

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials